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Abstract
Background Hyperhomocysteinaemia (HHC) is thought
to be a risk factor for cardiovascular disease including heart
failure. While numerous studies have analyzed the role of
homocysteine (Hcy) in the vasculature, only a few studies
investigated the role of Hcy in the heart. Therefore we have
analyzed the effects of Hcy on isolated cardiomyocytes.
Methods H9c2 cells (rat cardiomyoblast cells) and adult
rat cardiomyocytes were incubated with Hcy and were
analyzed for cell viability. Furthermore, we determined the
effects of Hcy on intracellular mediators related to cell
viability in cardiomyocytes, namely NOX2, reactive oxy-
gen species (ROS), mitochondrial membrane potential
(DWm) and ATP concentrations.
Results We found that incubation of H9c2 cells with
0.1 mM D,L-Hcy (= 60 lM L-Hcy) resulted in an increase
of DWm as well as ATP concentrations. 1.1 mM D,L-Hcy
(= 460 lM L-Hcy) induced reversible ﬂip-ﬂop of the
plasma membrane phospholipids, but not apoptosis. Incu-
bation with 2.73 mM D,L-Hcy (= 1.18 mM L-Hcy) induced
apoptosis and necrosis. This loss of cell viability was
accompanied by a thread-to-grain transition of the mito-
chondrial reticulum, ATP depletion and nuclear NOX2
expression coinciding with ROS production as evident
from the presence of nitrotyrosin residues. Notably, only at
this concentration we found a signiﬁcant increase in
S-adenosylhomocysteine which is considered the primary
culprit in HHC.
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Introduction
Hyperhomocysteinaemia (HHC) reﬂects an impairment of
the methionine–homocysteine metabolism. Normally
homocysteine (Hcy) is converted to cysteine via transsulf-
uration or to methionine by addition of a methyl group
donated by folate [1]. However, when these pathways are
deranged because of genetic mutations of enzymes involved
or relative deﬁciencies of folate, vitamin B6 or vitamin B12,
the serum concentration of Hcy increases [2, 3].
In 1969 Mc Cully et al. reported elevated concentrations
of Hcy in young patients with severe cardiovascular dis-
ease [4]. They hypothesized the existence of a pathogenic
link between HHC and atherogenesis. Since then other
studies have also suggested that HHC is an independent
risk factor for cardiovascular complications [5–8]. It is now
assumed that even mild HHC constitutes an independent
risk factor for cardiovascular disease [9] with equal pre-
dictive strength as hypercholesterolemia and smoking [10].
Whether Hcy itself or a Hcy-related substance such as
S-adenosyl-homocysteine (SAH) is the culprit, and what
the exact pathogenic mechanism of the cardiovascular
complications induced by HHC could be, remains to be
elucidated. In addition, large-scale intervention trails using
high-dose-B-vitamins to reduce plasma Hcy levels in car-
diovascular patients have as yet not shown an overall
clinical beneﬁt [11–13]. This raises further questions about
the mechanisms underlying the association between HHC
and cardiovascular disease, and about the possible adverse
effects of high-dose-B-vitamins as a means of reducing
Hcy levels [14].
Studies on the effects of Hcy on the vascular wall,
especially on endothelial and smooth muscle cells, indicate
that increased Hcy leads to cellular stress and also to cell
damage [15–17]. Hcy primes human neutrophils for an
increased production of reactive oxygen species (ROS) and
induces ROS production in endothelial cells [15, 18]. ROS
production has also been found in the vascular wall of
coronary arteries during HHC [19] and a role of NADPH
oxidases in this process has been suggested.
From the Framingham Heart Study it is known that in-
creased plasma homocysteine concentrations, next to their
effect on the vasculature, also form an independent risk
factor for the development of heart failure [20]. Several
other studies have also shown a link between HHC and
heart failure [21, 22]. However, so far no studies have
addressed possible effects of Hcy on cardiomyocytes.
Therefore, we performed the present study to analyze the
effects of Hcy on isolated cardiomyocytes.
Materials and methods
Cell cultures
Rat cardiomyoblasts (H9c2 (2–1) cells; ATCC, Manassas,
VA, USA) were cultured in Dulbecco’s Modiﬁed Eagles
Medium (DMEM; BioWhittaker, Verviers, Belgium) sup-
plemented with 10% heat-inactivated fetal calf serum
(FCS; BioWhittaker), 2 mM L-glutamine (GIBCO, Paisley,
UK), 100 IU/ml penicillin (Yamanouchi Europe BV,
Leiderdorp, Netherlands) and 100 lg/ml streptomycin
(Radiopharma-Fisiopharma, Palomonte, Italy), and grown
at 37 C in a humidiﬁed 5% CO2/95% air atmosphere.
Experiments were performed with cells grown to a con-
ﬂuency of 60–80%. Adult rat cardiomyocytes were isolated
as described before [23].
Antibodies and chemicals
Monoclonal Antibody 48 against NOX2 IgG 1 (dilution
1:28) was obtained from Sanquin Research at CLB,
Amsterdam, The Netherlands [24]. Cy3-labeled goat-anti-
rabbit-Ig (1:75) (Alexa Fluor; Leiden, Netherlands) was
used as a secondary antibody. Polyclonal a-Nitrotyrosine
IgG (1:50) (Molecular Probes Inc, Eugene, OR, USA) was
used as an antibody to measure nitrotyrosin residues which
is an indicator for ROS production. In this case,
Cy5-labeled goat-anti-rabbit-Ig (1:50) (Jackson Immuno
Research, West Grove, PA, USA) was used as a secondary
antibody. Isotype controls and PBS were used to determine
aspeciﬁc binding. Monoclonal antibody 1501R against
pan-actin (1:6000; Chemicon International, Inc, Temecula,
CA, USA) was used as a loading control for the western
blot analysis.
Cells were incubated with several concentrations
(0.1 mM–2.7 mM) of D,L-homocysteine (Hcy) (Sigma, St.
Louis, MO, USA) in growth medium for 24 h at 37 Ci na
humidiﬁed 5% CO2/95% air atmosphere.
Measuring Hcy concentration in growth medium
The H9c2 cells were incubated with different concentra-
tions of D,L-Hcy. Several studies have suggested that only
the L form is bioactive [25, 26]. Next to D,L-Hcy concen-
tration we therefore also measured the L-form. D,L-Hcy was
measured by HPLC using ﬂuorescence detection [27].
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std dev/average *100%) were 1.8 and 3.5%, respectively.
L-Hcy was measured by the Abbott IMx ﬂuorescence
polarization immunoassay (IMx; Abbott Laboratories,
Abbott Park, IL, USA). Intra- and interassay CVs were less
than 2 and 4%, respectively. The concentration of Hcy in
culture medium was measured before incubation (t =0 )
and after 24 h (ﬁnal timepoint for the rest of the experi-
ments) of incubation with H9c2 cells to determine the
amount of putative degradation and/or uptake of the Hcy
during this incubation period.
Determination of intracellular S-Adenosylmethionine
(SAM) and S-Adenosylhomocysteine (SAH)
Since previous studies suggested that an increase in SAH is
the culprit in cellular damage due to elevated levels of Hcy,
we also determined the intracellular concentration of SAM
and SAH in H9c2 cells after 24 h of incubation with D,L-
Hcy. Tandem mass spectrometry (MS/MS) was used for
the determination of SAM/SAH concentrations as previ-
ously described [28].
Flow cytometry
Phosphatidylserine exposure was assessed with FITC-la-
beled human recombinant annexin-V (Bender Med Systems,
Vienna, Austria), while propidium iodide (PI; Bender Med
Systems) was used to determine the permeability of the
cellular membrane. Experiments were performed in the
presence or absence of Z-Asp-Glu-Val-Asp-ﬂuorometh-
ylketone (Z-VAD FMK, 25 lM, Alexis Biochemicals,
Lausen, Switzerland), a general caspase inhibitor, to dif-
ferentiate between reversible ﬂip-ﬂop of plasma membrane
phospholipids, apoptosis and necrosis [23]. After treatment
with Hcy, the cells were trypsinized and centrifuged at
400g for 5 min at room temperature. Cells were then
washed with serum-free DMEM, and resuspended in serum
free DMEM containing annexin V (1:40) for 30 min in the
dark at 37 C in a humidiﬁed 5% CO2/95% air atmosphere.
Cells were subsequently washed and resuspended in serum
free DMEM containing PI (1:40). Cells were measured
with a FACSCalibur (Becton Dickinson, San Jose, CA,
USA). Results were analyzed by Cell Quest Pro software
(Becton Dickinson).
Detection of caspase-3 activity
Cells were grown in a 96–wells plate (20,000 cells/well).
After treatment with Hcy and/or Z-VAD FMK, cells were
lysed and incubated with DEVD-rhodamine 110 substrate
(Roche, Mannheim, Germany) for 1 h at 37 C. Subsequently
the amount of free rhodamine was determined at a microplate
ﬂuorescence reader (TECAN spectraﬂuor, Switzerland). The
developed ﬂuorochrome was proportional to the concen-
tration of activated caspase-3 and could be quantiﬁed by a
calibration curve of diluted free rhodamine. Each condition
was measured in triplo per measurement (total of three
measurements).
Immunoﬂuoresence microscopy
To measure the expression of NOX2 and the putative
formation of nitrotyrosin, cells were incubated with or
without Hcy for 24 h in the 4-well chamber slides (Nalge
Nunc International, Naperville, IL, USA). Cells were
washed with PBS and ﬁxated with 4% formaldehyde for
10 min at 37 C. Cells were subsequently washed with PBS,
permeabilized with acetone–methanol (70%–30%) for
10 min at –20 C, and then washed again with PBS/Tween-
20 (0.05% (v/v) Tween-20 in PBS). Subsequently cells
were incubated with primary antibodies against NOX2 and
nitrotyrosin for 60 min at room temperature followed by
incubation overnight at 4 C. PBS and isotype controls were
also tested to determine nonspeciﬁc binding of the anti-
bodies and background signal. The following day the cells
were washed with PBS/Tween and incubated with the
secondary antibodies for 30 min at room temperature.
After subsequent washes in PBS/Tween and PBS, the slides
were covered in mounting medium containing DAPI
(Vector Laboratories Inc, Burlingame, CA, USA) to visu-
alize nuclei. Thereafter the slides were covered with cov-
erslips.
Subsequently, cells were analyzed by means of a 3I
Marianas
TM digital imaging microscopy workstation (Zeiss
Axiovert 200 M inverted microscope; Carl Zeiss, Sliedr-
echt, Netherlands), equipped with a nanostepper motor
(Z-axis increaments; 10 nm) and a cooled CCD camera
(Cooke Sensicam, 1280 · 1024 pixels; Cooke Co, Tona-
wanda, NY, USA). Visualization of NOX2 and nitrotyrosine
was performed with a 40· air lens. The microscope,
camera and data viewing process were controlled by
SlideBook
TM software (version 4.0.8.1; Intelligent Imaging
Innovations, Denver, CO, USA).
Live cell analysis of DWm
To visualize mitochondrial membrane potential (DWm) via
Life Cell Imaging, cells were loaded for 30 min at 37 C
with 0.5 lmol/l of 5,5¢,6,6¢-tetrachloro-1,1¢,3,3¢-tetraeth-
ylbenzimidazolylcarbocyanine iodide (JC-1; Cell Tech-
nology Inc, Minneapolis, USA). In non-apoptotic cells,
JC-1 exists as a monomer and is visible on the green
channel (FITC). In healthy cells these monomers accumulate
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These aggregates are visible on the red channel (CY3)
when viewed with a ﬂuorescence microscope. Cells were
washed with PBS before viewing and subsequently analyzed
by use of a 3I Marianas
TM digital imaging microscopy
workstation as described above.
Western blot analysis
After treatment H9c2 cells were harvested into modiﬁed
ELB lysis buffer (250 mM NaCl, 0.1% Nonidet P-40,
50 mM HEPES pH 7.0, 5 mM EDTA, 0.5 mM DTT)
wherein protease inhibitor cocktail (PIC, 1:40; Sigma) was
added, and the cell suspension was mixed rigorously and
then incubated for 30 min on ice. After determination of
the protein concentration of the samples with the BCA
protein assay kit (Pierce, Rockford, IL, USA), reducing
sample loading buffer (0.25 M TRIS pH 6.8, sodium
dodecyl sulfate (SDS), glycerol, 2-mercaptoethanol,
bromophenol blue) was added and the samples were mixed
and heated at 95 C for 10 min. A total of 50 lg protein of
each sample was then subjected to SDS-PAGE, transferred
to nitrocellulose membranes and analyzed for NOX2
expression with monoclonal antibody 48 (1:250 dilution)
and for pan-actin with monoclonal antibody 1501R as a
loading control (1:6000), followed by horseradish–peroxi-
dase–conjugated rabbit–anti-mouse immunoglobulins
(RaM-HRP; 1:1000 dilution; DakoCytomation, Glostrup,
Denmark). The blots were visualized by enhanced chemi-
luminescence (ECL; Amersham Biosciences AB; Uppsala;
Sweden). Staining was quantiﬁed with a charge-coupled
device camera (Fuji Science Imaging Systems; Du ¨sseldorf,
Germany) in combination with AIDA Image Analyzer
software (Isotopenmessgera ¨te; Staubenhardt, Germany).
ATP measurement via Luciferase–Luciferin assay
After treatment cells were collected by trypsinization and
centrifugation at 400g for 5 min. Cells were then counted
and equal amounts were taken per condition. After cen-
trifugation for 2 min (400g) the supernatant was discarded.
The pellet was resuspended in 150 ll of ice-cold perchloric
acid (PCA) 0.4 M. Cells were left on ice for 30 min and
then centrifuged again for 5 min (2000g)a t4  C. To the
isolated supernatant 7.5 llo fK 2CO3 5 M was added to
neutralize pH. Samples were subsequently stored at –80 C
until measuring. The amount of ATP in the samples was
determined with a Luciferase–Luciferin assay (Biafﬁn
GmbH & Co KG, Kassel, Germany) according to the
manufacturers’ protocol. Samples were measured in a
FluoroNunc MaxiSorp plate (Nalge Nunc International,
Rochester, NY). Luminescence was measured by using a
Tecan GENios Plus reader (Tecan Benelux, Mechelen,
Belgium).
Statistics
Statistics were performed with the SPSS statistics program
(windows version 9.0). To evaluate whether observed dif-
ferences were signiﬁcant, One Way ANOVA with post hoc
Bonferroni tests were used. All values are expressed as
mean ± standard error of the mean (SEM). A P value (two
sided) of 0.05 or less was considered to be signiﬁcant.
Results
Measurement of the concentration of D,L-homocysteine
(D,L-Hcy), L-homocysteine (L-Hcy), S-adenosyl
methionine (SAM) and S-adenosyl homocysteine
(SAH)
We tested the effects of D,L-Hcy at concentrations of
0.1 mM, 1.1 mM and 2.7 mM, in accordance with previ-
ous studies in isolated vascular cells [15, 17, 26, 29–31].
We quantiﬁed the exact concentration of D,L-Hcy in med-
ium added to the cells, via HPLC. As depicted in Table 1,
the concentration of D,L-Hcy was according to the con-
centration added to the growth medium.
Since previous studies have shown that only the L form
of Hcy is bioactive [25, 26], we also determined the L-Hcy
concentration in medium by IMx. We found that 42.7%,
42.5% and 43.3% of the total D,L-Hcy amount 0.1 mM,
1.1 mM and 2.7 mM, respectively, in fact was L-Hcy at
t = 0. Furthermore, we determined the concentrations of
L-Hcy at 24 h, the ﬁnal time point of incubation, and found
a signiﬁcant decrease in the concentrations of L-Hcy,
namely for 1.1 mM a signiﬁcant decrease of 0.14 mM
L-Hcy; +/–0.011 (P < 0.001) and for 2.7 mM a signiﬁcant
decrease of 0.34 mM L-Hcy; +/–0.0301 (P < 0.001).
It has been well documented that increased levels
of SAH inhibit several important methylation reactions
[32–34]. Therefore we also determined the intracellular
concentrations of both SAH and SAM, being one of the
primary methyl donors (Table 1). Measuring intracellular
concentrations of SAM and SAH in H9c2 cells incubated
with and without D,L-Hcy showed a signiﬁcant depletion
of SAM at 2.7 mM D,L-Hcy compared to untreated cells
and 0.1 mM D,L-Hcy treated cells (P = 0.006; n = 3).
While the concentration of SAH increased signiﬁcantly at
this same concentration compared to all other conditions
(P < 0.001; n = 3). Therefore we also examined the
effects of the higher, non-physiological concentrations of
Hcy.
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We analyzed the effect of Hcy on H9c2 cell viability by
measuring annexin V and/or PI positivity using ﬂow-
cytometry. Incubation with 0.1 mM D,L-Hcy had no effect
on single-annexin-V-positivity (Fig. 1A), double-annexin-
V, PI positivity (Fig. 1B) or single-PI positivity (not
shown, approximately 3% for each condition). In contrast,
incubation with 1.1 mM D,L-Hcy resulted in a signiﬁcant
increase in single- annexin-V-positive cells (P < 0.002)
(Fig. 1A). This increase in single-annexin-V-positive cells
was only partly, but not signiﬁcantly inhibited by Z-VAD
FMK (31.6% decrease).1.1 mM D,L-Hcy had no signiﬁcant
effect on the percentage of double-annexin-V/PI-positive
cells (Fig. 1B) or on the percentage of single-PI-positive
cells (not shown). Incubation with 2.7 mM D,L-Hcy, how-
ever, resulted in a signiﬁcant increase of single-annexin-V
positive cells (P < 0.001) and double-annexin-V/PI-posi-
tive cells (P < 0.044) that could not be inhibited signiﬁ-
cantly by Z-VAD FMK. Again we did not see any
signiﬁcant increase in single-PI-positive cells (not shown).
Thus, depending on the concentration of Hcy, either
reversibly ﬂip-ﬂopped cardiomyocytes and/or late apopto-
tic/necrotic cells can be found.
Caspase-3 activity
To determine whether the population of double-annexin-V/
PI-positive cells consists of late apoptotic cells or necrotic
cells, we performed an assay of caspase-3 activity. Incu-
bation with 0.1 mM and 1.1 mM D,L-Hcy did result in a
small, but not signiﬁcant increase in caspase-3 activity that
was completely inhibited when Z-VAD FMK was added.
Incubation with 2.7 mM D,L-Hcy for 24 h, however,
induced a signiﬁcant increase of caspase-3 activity
(P < 0.001) that was also completely inhibited with
Z-VAD FMK (Fig. 2). Caspase-3 activity measured at
earlier time points (6 and 16 h) of Hcy incubation was not
signiﬁcantly increased (results not shown). Thus, signiﬁcant
apoptosis induction of H9c2 cells was only present at
2.7 mM D,L-Hcy.
Table 1 Concentration of D,L-Hcy and L-Hcy in culture medium on t =0 ,L-Hcy after 24 h incubation, and intra-cellular concentration of SAM/
SAH after 24 h incubation
mM Hcy added mM Hcy measured [SAM] (nM) t = 24 [SAH] (nM) t =2 4
[D,L-Hcy] [L-Hcy] t =0 [ L-Hcy] t =2 4
0.0 0 0.0007 (+/–0.00009) 0.002 (+/– 0.00004) 464.9 (+/– 36.6) 6.3 (+/– 0.7)
0.1 0.14 (+/– 0.03) 0.06 (+/– 0.01) 0.06 (+/– 0.01) 468.3 (+/– 77.2) 7.0 (+/– 2.9)
1.1 1.08 (+/– 0.04) 0.46 (+/– 0.03) 0.32 (+/– 0.01)* 319.6 (+/– 56.2) 16.9 (+/– 6.8)
2.7 2.73 (+/– 0.06) 1.18 (+/– 0.05) 0.84 (+/– 0.03)* 204.4 (+/– 74.5)
** 164.8 (+/– 34.6)***
All mediators were measured in n = 3. A signiﬁcant decrease of L-Homocysteine (L-Hcy) can be seen at 1.1 mM and 2.7 mM after 24 h
(* P < 0.001). At 2.7 mM a signiﬁcant decrease of S-adenosylmethionine (SAM,
** P = 0.006); but an increase in S-adenosylhomocysteine
(SAH, *** P < 0.001) was detected, compared to all other concentrations
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Fig. 1 Effect of Hcy on cell-viability via ﬂow-cytometry: Flow
cytometry analysis of H9c2 cells incubated with different concentra-
tions of D,L-Hcy during 24 h, with or without 25 lM Z-VAD FMK, a
pan caspase inhibitor. A total of 10,000 cells were measured (n = 3).
(A) Percentage of single annexin V positive, PI-negative labeled cells,
which is a marker of ﬂip ﬂop of the plasma membrane phospholipids.
(B) Percentage of double-annexin-V/PI-positive cells depicting late
apoptotic and/or necrotic cells. Data represent mean percentages and
standard error of the mean (SEM)
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In a previous study we have found that ischemia of car-
diomyocytes induced nuclear NOX2 expression coinciding
with nuclear nitrotyrosine residues, resulting in subsequent
apoptosis of these cells [35]. Given the pro-apoptotic effect
of 2.7 mM D,L-Hcy, we analyzed by Western blotting the
effect of Hcy on NOX2 expression. We found that NOX2
was constitutively present in whole cell lysates of H9c2
cells (Fig. 3). NOX2 expression was slightly increased at
0.1 mM D,L-Hcy and increased even more at concentrations
of 1.1 mM and 2.7 mM of D,L-Hcy. It is noteworthy that
although we found this increase in NOX2 expression, we
were not able to detect apoptosis at the lower concentra-
tions of Hcy. Therefore we subsequently analyzed the
intracellular localization of NOX2 with digital imaging. In
the cytosol, we found diffuse positivity for NOX2 at all
concentrations of Hcy (data not shown). Incubation with
0.1 mM and 1.1 mM, but especially with 2.7 mM D,L-Hcy
resulted in a signiﬁcant increase in NOX2 expression in the
nucleus (P < 0.001; P = 0.047; P < 0.001, respectively)
(Fig. 4A). These results appear in contrast with the cas-
pase-3 measurements. We therefore also analyzed the
presence of nitrotyrosine residues as an indicator for ROS
production. We found that neither 0.1 mM nor 1.1 mM
D,L-Hcy resulted in signiﬁcant nitrotyrosine formation
in the nucleus. In contrast, 2.7 mM D,L-Hcy did induce
a signiﬁcant formation of nitrotyrosine residues in the
nucleus (P < 0.001) (Fig. 4B). These results underline that
not only nuclear NOX2 expression but also nuclear ROS
production is necessary for the induction of apoptosis. It
has to be noticed that especially at 2.7 mM D,L-Hcy a
signiﬁcant loss of approximately 50% of the cells was
found (P < 0.001, results not shown). As these cells theo-
retically are predominantly double-annexin-V/PI or single-
PI-positive, we conclude that the effect of incubation with
2.7 mM D,L-Hcy on the amount of double-annexin-V/PI or
single-PI-positive cells (see Fig. 1) in all probability is
underestimated.
We next wanted to corroborate the ﬁndings of NOX2-
mediated nitrotyrosine formation in adult rat cardiomyo-
cytes. Because the Hcy concentrations analyzed in H9c2
cells were lethally toxic for adult rat cardiomyocytes, we
used lower concentrations for these cells. Incubation with
0.07 mM D,L-Hcy induced signiﬁcant NOX2 expression in
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Fig. 2 Effect of Hcy on caspase-3 activity: H9c2 cells were
incubated during 24 h with different concentrations of D,L-Hcy in
the presence and absence of Z-VAD FMK (n = 9). Caspase-3 activity
was measured as indicated under Methods. Data represent mean and
SEM
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Fig. 3 Effect of Hcy on NOX2 expression: (A) Western Blot analysis
for NOX2 expression of whole-cell lysates from H9c2 cells incubated
with or without Hcy for 24 h. Data represent mean and SEM for three
independent experiments. (B) Western Blot analysis of the same blots
for pan-actin as a loading control
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123the nucleus (P < 0.022; Fig. 5D) but no signiﬁcant ni-
trotyrosine formation. Incubation with 0.1 mM D,L-Hcy led
to signiﬁcant nuclear NOX2 expression and presence of
nitrotyrosine residues (P < 0.01; Fig. 5A–E). As with
H9c2 cells, we found only little NOX2 positivity in the
cytosol under all Hcy concentrations analyzed (arrow in
Fig. 5A).
ATP depletion
An important determinant in the process of cell death is
ATP, as it is for instance necessary to complete the process
of apoptosis. We therefore measured ATP concentrations
in H9c2 cells (Fig. 6). Incubation with 0.1 mM D,L-Hcy
resulted in a signiﬁcant increase in ATP concentration
(P = 0.05). In contrast, incubation with 1.1 mM D,L-Hcy
led to a decrease in ATP concentration that was not sig-
niﬁcant compared to control cells, but was signiﬁcant
compared to ATP concentration found in cells that were
incubated with 0.1 mM D,L-Hcy (P = 0.024). Incubation
with 2.7 mM D,L-Hcy induced an more pronounced
decrease of ATP concentration that was signiﬁcant also
when compared to control cells (P = 0.036).
DWm
To explain the contrasting effects of different Hcy con-
centrations on ATP concentrations, we analyzed the
mitochondrial membrane potential (DWm) with JC-1
staining in H9c2 cells. We found an increase in red signal
(P = 0.006) when the H9c2 cells were incubated with
0.1 mM D,L-Hcy compared to control cells (Fig. 7A/B)
which is indicative for more actively respiring mitochon-
dria. DWm after incubation with 1.1 mM and 2.7 mM
D,L-Hcy did not differ signiﬁcantly from that in control
cells (Fig. 7A–E). A difference in the morphology of
mitochondria was also visible. In control cells a hetero-
zygous mitochondria population is visible consisting of
round and elongated mitochondria. Incubation with
0.1 mM D,L-Hcy showed mostly elongated mitochondria,
whereas incubation with 1.1 mM and 2.7 mM D,L-Hcy
resulted in a more rounded morphology of the mitochon-
dria, the so called thread-to-grain transition which is seen
as an early marker for apoptosis [36].
Discussion
In the present study we examined the effects of Hcy on cell
viability of cardiomyocytes and found different effects,
depending on Hcy concentration (Fig. 8).
The lower concentration of 0.1 mM Hcy resulted in
mitochondrial hyperpolarization, an increase of ATP and
translocation of NOX2 to the nucleus but without local
nitrotyrosin formation. Mitochondrial hyperpolarization
and an increase in ATP concentration have been described
as ﬁrst signs of mitochondrial disturbance on the pathway
to apoptosis [36, 37]. On the other hand, they have also
been described as part of a cell-protective mechanism [38].
Therefore, the effect of this lower Hcy concentration may
be a cellular state characterized by early activity of both
pro- and anti-apoptotic pathways, which does not neces-
sarily result in cell death.
In contrast, the intermediate concentration of 1.1 mM
Hcy led to rounding of mitochondria, a slight, non signif-
icant decrease of DWm with a visible thread-to-grain tran-
sition of the mitochondrial reticulum, a slight decrease in
ATP concentrations, a translocation of NOX2 to the
nucleus, again without presence of nitrotyrosin residues,
and a ﬂip-ﬂop of the cell membrane phospholipids as
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Fig. 4 Effect of Hcy on intracellular localization of NOX2 and
nitrosylation in H9c2 cells: Analysis of the effect of different
concentrations of D,L-Hcy at 24 h incubation on the nuclear
localization of NOX2 expression (A) and nitrotyrosine residues (B)
measured by means of digital imaging microscopy. The arbitrary units
are deﬁned as sum intensity per nucleus and depicted as % increase
versus control where control was set to 0 (n = 6). Data represent mean
and SEM
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123indicated by single annexin v positivity. We did not ﬁnd
caspase-3 activation at this concentration. Although ann-
exin V positivity of cells has generally been considered as a
marker for apoptosis, in a previous study however, we have
demonstrated that this is not absolute as such and that
membrane phospholipid ﬂip-ﬂop can be reversible [23],
which is supported in this study by the observation that
complete inhibition of caspases by Z-VAD-FMK did not
affect this phenotype. The caspase-dependent pathway of
apoptosis was, therefore, not yet activated at this concen-
tration of Hcy, probably related to the lack of nuclear ni-
trotyrosin residues.
The highest concentration of 2.7 mM Hcy entailed a
completion of the thread-to-grain transition of the mito-
chondrial reticulum, a further decrease of ATP, transloca-
tion of NOX2 to the nucleus and nuclear nitrotyrosin
formation, caspase-3 activation, and also a clear increase in
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Fig. 5 Effect of Hcy on
intracellular localization of
NOX2 and ROS production in
adult rat cardiomyocytes:
Digital Imaging microscopy
pictures of adult rat
cardiomyocytes incubated with
0.1 mM D,L-Hcy during 24 h.
Red color (A) indicates NOX2
expression which is visible in
the nucleus and in the cytosol
(arrow). Green color (B)
represents nitrotyrosine
formation. The merge image
(C) also shows blue DAPI
staining for DNA which shows
co-localization of NOX2
expression and nitrotyrosine
formation in the nucleus. (D)
Amount of nuclear NOX2
expression in adult rat
cardiomyocyt in control,
0.07 mM and 0.1 mM D,L-Hcy
samples (n = 3). (E) Amount of
nitrotyrosine formation in adult
rat cardiomyocyt in control,
0.07 mM and 0.1 mM D,L-Hcy
sample (n = 3). The arbitrary
units are deﬁned as sum
intensity per nucleus and
depicted as % increase versus
control where control was set to
0. Data represent mean and
SEM
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123both single-annexin-V and annexin-V/PI-positive cells.
These changes represent a cellular phenotype irreversibly
committed to cell death, in which nuclear ROS production
apparently plays a deciding role as indicated by the pres-
ence of nitrotyrosin residues. Whether cell death then fol-
lows the process of apoptosis or necrosis depends on the
remaining concentration of ATP. Apoptosis is energy
consuming, and therefore depends on minimal residual
ATP concentrations, whereas necrosis is the default route
in the absence of ATP [39].
Induction of apoptosis generally follows one of two
pathways. The ﬁrst pathway, the death receptor or extrinsic
pathway, is activated by ligand binding of cell-surface-
expressed death receptors. The second pathway, the mito-
chondrial or intrinsic pathway, is promoted by physical or
chemical stress agents [40]. Intracellular accumulation of
Hcy and its metabolites constitutes considerable intracel-
lular stress [15, 17, 41]. In line with this notion, several
studies in endothelial cells have suggested that Hcy-in-
duced apoptosis follows the mitochondrial pathway
[42,43]. Our study in cardiomyocytes has shown that DWm
is modiﬁed in a concentration-dependent manner, and
thereby supports the concept that Hcy-induced apoptosis
mainly follows the mitochondrial pathway, also in car-
diomyocytes. However, in addition we found that translo-
cation of NOX2 to the nucleus coinciding with the
presence of nitrotyrosin residues indicative for ROS pro-
duction is even more important in the effector phase of the
process of apoptosis induction in cardiomyocytes.
Since we only found a signiﬁcant decrease in L-Hcy at
the highest concentrations, but not with 0.1 mM D,L-Hcy
we also determined SAH concentrations. Several studies
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Fig. 7 Effect of Hcy on
mitochondrial membrane
potential: H9c2 cells were
incubated with or without Hcy
for 24 h and analyzed with
digital imaging microscopy.
Green indicates the JC-1
monomers. Red indicates JC-1
aggregates, which are formed in
the mitochondria when a
sufﬁciently high membrane
potential is reached. (A) H9c2
cells incubated in growth
medium alone. Normal
heterozygous population of
elongated and round
mitochondria have a red
ﬂuorescence signal. (B) H9c2
cells incubated with 0.1 mM
D,L-Hcy. An increase in actively
respiring mitochondria (red) is
visible, and a mostly elongated
morphology can be seen. (C)
1.1 mM D,L-Hcy shows a
similar amount of functioning
mitochondria in the cells that
did not receive Hcy; only the
morphology of the mitochondria
is mostly round, a phenomenon
which is known as thread-to-
grain transition. (D) H9c2 cells
incubated with 2.7 mM D,L-
Hcy. Some cells have no
functioning mitochondria left,
but overall there is no
signiﬁcant loss of red signal.
The thread-to-grain transition of
the mitochondrial reticulum is
complete. (E) Analysis of sum
intensity in Cy3 signal (red) per
condition as an indicator for
DWm. Data represent mean and
SEM (n =3 )
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123provided further evidence that SAH could be the culprit in
Hcy-mediated damage since it is a potent inhibitor of
various methylation reactions [32–34]. In this study we
found that only the concentration of 2.7 mM D,L-Hcy
resulted in a signiﬁcant increase in SAH, which was the
concentration that resulted in cell death of cardiomyocytes.
Therefore our study underlines that SAH is an important
mediator in the induction of cell death of cardiomyocytes
by Hcy.
A limitation of the present study is the use of relatively
high concentrations of Hcy. However, it should be noted
that cells in culture usually up-regulate their Hcy-metab-
olizing enzymes, in particular cystathionine beta-synthase
(CBS) [44]. Furthermore short-term exposure to high Hcy
concentrations may reﬂect a prolonged exposure to mod-
erately elevated Hcy concentrations as occur life-long in
patients. Therefore, our data may provide, at least in part,
an explanation why HHC contributes to heart failure.
Conclusion
Hcy is increasingly recognized as an independent cardio-
vascular risk factor [5–8] and an extensive literature exists
that links Hcy-induced changes in endothelial [15, 26,
45–48] and smooth muscle cells [16, 17, 49–52] to ath-
erosclerotic disease. The Framingham Heart Study also
showed that increased plasma Hcy levels are a risk factor
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Fig. 8 Effects of different
concentrations of Hcy on
cardiomyocyte viability Scheme
of the proposed events caused
by Hcy, which ultimately lead
to cell death: (A) control cells.
(B) 0.1 mM D,L-Hcy results in
increase of DWm and ATP
levels, and translocation of
NOX2 to the nucleus. (C)
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ﬂop of the plasma membrane
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NOX2 in the nucleus. (D)
2.7 mM D,L-Hcy next to ﬂip-
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the nucleus, nuclear ROS
production is found. ATP is then
decreased, as well as DWm.
Caspase-3 is activated and PI
can enter the cell indicating cell
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123for the development of heart failure [20]. To our knowl-
edge, no reports have yet been published on the effect of
Hcy on cardiomyocytes speciﬁcally. Our study now clearly
indicates that Hcy, and possible SAH, indeed affects also
cardiomyocytes, primarily by inducing apoptosis/necrosis
in a concentration-dependent manner, in which nuclear
ROS production, related to nuclear NOX2 expression, is
crucial.
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